VNDA
VandaDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The bull case is that Q1 contained several real positives at once: Fanapt growth was strong, NEREUS launched, BYSANTI already has FDA approval, full-year revenue guidance was raised, and imsidolimab still offers a meaningful December 2026 regulatory shot on goal [#8-K-2026-05-06].
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +0.0.
What can break
Cash, cash equivalents and marketable securities were $202.3 million at March 31, 2026 after a $61.5 million quarterly decline, including a $10 million NEREUS-related milestone payment, so runway and spend discipline remain important [#8-K-2026-05-06].
Momentum
21
Value
41
Sentiment
63
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $6.90 · Bull $10.50 · Bear $4.25
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $14.88
Why
Momentum21 · Δ7d +2.6
Value41 · Δ7d +0.1
Sentiment63 · Δ7d +0.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
21
34% active weight
Current posture
7d trendImproving
Δ7d
+2.6
Δ21d
+4.2
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
63
33% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+6.7
Why this grade
Composite grade D. Momentum 21.5 / Value 41.1 / Sentiment 63.3
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$382.76M
Beta
0.63
Shares Out
59.1M
P/E (TTM) · Derived
-1.7
P/S (TTM)
2.19
P/FCF (TTM) · Derived
-4.59
Rev YoY
+18.1%
EPS YoY
-318.3%
Gross Margin
+94.4%
Op Margin
-57.1%
Net Debt
-$369.68M
Current Ratio
3.12
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology